NDC 17856-0353-2 - Pharbetol Regular strength

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
17856-0353
Requested NDC
17856-0353-2
Package NDCs from labels
17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
Manufacturer
ATLANTIC BIOLOGICALS CORP.
Effective date
2025-06-05
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
PHARBEST IBUPROFEN Drug FactsATLANTIC BIOLOGICALS CORP.2025-06-05HUMAN OTC DRUG LABEL
Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONSATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS2024-04-30HUMAN OTC DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
17856-0353-12024-06-26C16284748780-11030e365-250f-111a-e063-dadaa90a10e2PHARBEST IBUPROFEN Drug Facts
17856-0353-12024-01-30C16284748780-11030e365-250f-111a-e063-dadaa90a10e2PHARBEST IBUPROFEN Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-0353-1PharbetolRegular strength100 in 1 BOX, UNIT-DOSETABLET1003
17856-0353-2PharbetolRegular strength1 in 1 POUCHTABLET13
17856-0353-4PharbetolRegular strength24 in 1 BOTTLETABLET243
17856-0353-3PharbetolRegular strength28 in 1 BOTTLETABLET281

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-0353PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.]2Current NDC, Legacy NDC, 3 package rows20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip
17856-0353PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.]1Current NDC, Legacy NDC, 1 package rows20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 139 of 195 · 3,887 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NOTTS - Pain Relief PMACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDEVIVUNT PHARMA LLCe6754f62-e3b2-773f-e053-2a95a90ad36a2024-12-02WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine HydrochlorideACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEAAA Pharmaceutical, Inc.a242e005-0330-4afb-83b8-13c7d56f5c6d2024-12-02WarningsExact identifier
unii: 362O9ITL9D
Pain ReliefACETAMINOPHENAAA Pharmaceutical, Inc.a891896d-c9fa-4448-915a-e6b531157d222024-12-02WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Pain Relief Regular StrengthACETAMINOPHENTopCo Associates LLCc2d33352-431c-4683-a4fa-a54437e7b8d22024-12-02WarningsExact identifier
application number: M013
rxcui: 313782
unii: 362O9ITL9D
Pain Relief Extra StrengthACETAMINOPHENTopCo Associates LLCbdb01b3e-ad34-4003-9b9a-e83a2c0e90bb2024-12-02WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Aspirin 81mg Adult Low DoseASPIRINTopCare14d010fb-c4a1-4c3d-942f-58719727bfc02024-12-02WarningsExact identifier
application number: M013
AcetaminophenACETAMINOPHENCVS Pharmacy, Incc4473ee6-4e01-1ec2-e053-2995a90ac5132024-12-02WarningsExact identifier
application number: M013
unii: 362O9ITL9D
AspirinASPIRINProficient Rx LP9c186289-e309-45e8-8934-1d0eae0375c22024-12-01WarningsExact identifier
application number: M013
Childrens Chewable AcetaminophenACETAMINOPHENGERI-CARE PHARMACEUTICAL CORP22f63d62-c941-5b8f-e063-6394a90aeecd2024-11-28WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Extra Strength AcetaminophenACETAMINOPHENGeri-Care Pharmaceutical Corp7a7b6318-b7d6-31b1-e053-2991aa0abf252024-11-28WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Extra Strength Pain Reliever PMACETAMINOPHEN, DIPHENHYDRAMINE HCLINGLES MARKETS, INC.27fd288e-c07a-617f-e063-6394a90a17a42024-11-28WarningsExact identifier
application number: M013
unii: 362O9ITL9D
BAYER Aspirin Original, TRAVEL BASIXASPIRINLil' Drug Store Products, Inc.7f5d9ebe-8119-49a2-9380-eca18a5e5e852024-11-27WarningsExact identifier
application number: M013
EXCEDRIN MIGRAINEACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINEJones Healthcare Group - Packaging Services, Incc4168e4d-3dfc-4e51-a32e-14704cb59c662024-11-27WarningsExact identifier
application number: M013
unii: 362O9ITL9D
TYLENOL Extra Strength / TYLENOL Precise Cooling Pain ReliefACETAMINOPHEN, LIDOCAINE, MENTHOLKenvue Brands LLC2611e984-0dd5-bda1-e063-6394a90a559a2024-11-26WarningsExact identifier
application number: M013
Severe Sinus Congestion Allergy and Cough FormulaACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE , DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDEPuraCap Pharmaceutical LLC36a4ec1f-50c3-4d61-ada9-987ccad3563c2024-11-26WarningsExact identifier
unii: 362O9ITL9D
First Aid Only Extra-Strength Non-AspirinACETAMINOPHENAcme United Corporation6891d57a-10a6-53de-e053-2a91aa0ac7c22024-11-26WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Chewable AspirinASPIRINMARC GLASSMAN, INC.c8314910-71ff-5a55-e053-2995a90aafc72024-11-26WarningsExact identifier
application number: M013
AspirinASPIRINMarc Glassman, Inc.7990ca49-fb30-40fe-9ac4-48e89eac9bb22024-11-26WarningsExact identifier
application number: M013
Enteric Coated Aspirin Regular StrengthASPIRINSafeway96359eb6-62bc-4b13-960c-050af99a8c022024-11-26WarningsExact identifier
application number: M013
ASPIRIN Low DoseASPIRINMarc Glassman, Inc.3d519af3-9398-4439-8253-1e5d4612b8e32024-11-26WarningsExact identifier
application number: M013

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.